The compounds of the present invention are novel bicyclic triazole amino acid-derivatives useful as α4 integrin receptor antagonists. The invention is further directed to methods for treating integrin mediated disorders including, but not limited to, inflammatory, autoimmune and cell-proliferative disorders, methods for preparing the compounds and methods for preparing the intermediates, derivatives and pharmaceutical compositions thereof.
本发明的化合物是一种新型的双环三唑
氨基酸衍
生物,可用作α4整合素受体拮抗剂。本发明还涉及治疗整合素介导的疾病的方法,包括但不限于炎症、自身免疫和细胞增殖性疾病的方法,制备该化合物的方法以及制备其中间体、衍
生物和制药组合物的方法。